Entera Bio

ENTXNasdaq Israel Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$514.549 M

$2.96 +0.00%

Close of 21 Sept 2026

Revenue

$42.0K

#3609 by revenue

Earnings

-$11.4M

Loss-making

Shares outstanding

173,141,831

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#66RegenxbioRGNX$520.2M
#67Autolus TherapeuticsAUTL$516.4M
#68Entera BioENTX$514.5M
#69Ginkgo BioworksDNA$513.4M
#70Eikon TherapeuticsEIKN$478.3M

What if Entera Bio were worth as much as…

Open the what-if tool →

Gold $30.3T

$174,154.69

Per share 58,836× higher

Bitcoin $1.72T

$9,893.35

Per share 3,342× higher

Nvidia $5.48T

$31,523.46

Per share 10,650× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Entera Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.